157 related articles for article (PubMed ID: 16325559)
1. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors.
Koch HM; Angerer J; Drexler H; Eckstein R; Weisbach V
Int J Hyg Environ Health; 2005; 208(6):489-98. PubMed ID: 16325559
[TBL] [Abstract][Full Text] [Related]
2. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.
Koch HM; Preuss R; Angerer J
Int J Androl; 2006 Feb; 29(1):155-65; discussion 181-5. PubMed ID: 16466535
[TBL] [Abstract][Full Text] [Related]
3. Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation.
Koch HM; Bolt HM; Preuss R; Eckstein R; Weisbach V; Angerer J
Arch Toxicol; 2005 Dec; 79(12):689-93. PubMed ID: 16059725
[TBL] [Abstract][Full Text] [Related]
4. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
Koch HM; Bolt HM; Preuss R; Angerer J
Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
[TBL] [Abstract][Full Text] [Related]
5. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP).
Koch HM; Drexler H; Angerer J
Int J Hyg Environ Health; 2004 Jan; 207(1):15-22. PubMed ID: 14762970
[TBL] [Abstract][Full Text] [Related]
6. Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry.
Preuss R; Koch HM; Angerer J
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):269-80. PubMed ID: 15664359
[TBL] [Abstract][Full Text] [Related]
7. Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine.
Koch HM; Rossbach B; Drexler H; Angerer J
Environ Res; 2003 Oct; 93(2):177-85. PubMed ID: 12963402
[TBL] [Abstract][Full Text] [Related]
8. DEHP metabolites in urine of children and DEHP in house dust.
Becker K; Seiwert M; Angerer J; Heger W; Koch HM; Nagorka R; Rosskamp E; Schlüter C; Seifert B; Ullrich D
Int J Hyg Environ Health; 2004 Oct; 207(5):409-17. PubMed ID: 15575555
[TBL] [Abstract][Full Text] [Related]
9. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
Koch HM; Bolt HM; Angerer J
Arch Toxicol; 2004 Mar; 78(3):123-30. PubMed ID: 14576974
[TBL] [Abstract][Full Text] [Related]
10. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population.
Koch HM; Drexler H; Angerer J
Int J Hyg Environ Health; 2003 Mar; 206(2):77-83. PubMed ID: 12708228
[TBL] [Abstract][Full Text] [Related]
11. Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis.
Buchta C; Bittner C; Höcker P; Macher M; Schmid R; Seger C; Dettke M
Transfusion; 2003 Aug; 43(8):1115-20. PubMed ID: 12869118
[TBL] [Abstract][Full Text] [Related]
12. Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans.
Silva MJ; Samandar E; Preau JL; Needham LL; Calafat AM
Toxicology; 2006 Feb; 219(1-3):22-32. PubMed ID: 16332407
[TBL] [Abstract][Full Text] [Related]
13. Phthalic acid is the main metabolite of the plasticizer di(2-ethylhexyl) phthalate in peritoneal dialysis patients.
Mettang T; Alscher DM; Pauli-Magnus C; Dunst R; Kuhlmann U; Rettenmeier AW
Adv Perit Dial; 1999; 15():229-33. PubMed ID: 10682108
[TBL] [Abstract][Full Text] [Related]
14. 4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients.
Wahl HG; Hong Q; Hildenbrand S; Risler T; Luft D; Liebich H
Nephrol Dial Transplant; 2004 Oct; 19(10):2576-83. PubMed ID: 15280519
[TBL] [Abstract][Full Text] [Related]
15. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment.
Silva MJ; Reidy JA; Preau JL; Samandar E; Needham LL; Calafat AM
Biomarkers; 2006; 11(1):1-13. PubMed ID: 16484133
[TBL] [Abstract][Full Text] [Related]
16. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
Kato K; Silva MJ; Reidy JA; Hurtz D; Malek NA; Needham LL; Nakazawa H; Barr DB; Calafat AM
Environ Health Perspect; 2004 Mar; 112(3):327-30. PubMed ID: 14998748
[TBL] [Abstract][Full Text] [Related]
17. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit.
Calafat AM; Needham LL; Silva MJ; Lambert G
Pediatrics; 2004 May; 113(5):e429-34. PubMed ID: 15121985
[TBL] [Abstract][Full Text] [Related]
18. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants.
Green R; Hauser R; Calafat AM; Weuve J; Schettler T; Ringer S; Huttner K; Hu H
Environ Health Perspect; 2005 Sep; 113(9):1222-5. PubMed ID: 16140631
[TBL] [Abstract][Full Text] [Related]
19. Di(2-ethylhexyl)phthalate exposure of apheresis donors is procedure-related.
Weisbach V; Koch HM; Angerer J; Eckstein R
Transfusion; 2006 Aug; 46(8):1457-8; author reply 1459. PubMed ID: 16934089
[No Abstract] [Full Text] [Related]
20. Exposure to Di(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report.
Latini G; De Felice C; Presta G; Del Vecchio A; Paris I; Ruggieri F; Mazzeo P
Biol Neonate; 2003; 83(1):22-4. PubMed ID: 12566679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
